TSE:4547Pharmaceuticals
Kissei Pharmaceutical (TSE:4547) Valuation in Focus After Strong H1 Results and Upgraded Outlook
Kissei Pharmaceutical (TSE:4547) shares are drawing attention after the company reported a 7.9% year-over-year jump in net sales for the first half of fiscal 2025. Profits and financial forecasts are now trending higher.
See our latest analysis for Kissei Pharmaceutical.
Kissei Pharmaceutical’s latest financial results have come on the heels of new international licenses, a recent product launch in South Korea, and a noticeably more robust R&D push. While the share price slipped over the...